approval to build upon its open-label Phase II trial of RECCE ® 327 Topical Gel (R327G) for the treatment of diabetic foot infections (DFI), enabling the enrollment of up to 20 additional patients.

approval to build upon its open-label Phase II trial of RECCE® 327 Topical Gel (R327G) for the treatment of diabetic foot infections (DFI), enabling the enrollment of up to 20 additional patients.

Vascarta is launching a proof-of-concept Phase 1 clinical study to test its topical curcumin gel VAS-101 — which uses a component of turmeric — in people with sickle cell disease (SCD). The ...

SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), a leading developer of a new class of synthetic anti-infectives, today announced it ...

The results of the FM71 trial of MED3000 showed that the topical gel formulation achieved a significant improvement in erectile function compared to baseline at 24 weeks, across the range of mild ...

Dermatology company based in Philadelphia and Phoenix (US) which recently secured FDA approval for its product Sofdr (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used ...

Primary care doctors, physical therapists and orthopaedists can play an important role in treating osteoarthritis. Here’s the latest evidence on a growing range of options for treating OA pain, ...

Those who have aspirin allergies or take blood thinners for heart disease may be at higher risk. Lidocaine is a topical anesthetic that relieves pain by creating a numbing sensation. It works by ...

Almirall is expanding its business by buying Allergan’s dermatology portfolio. The Spanish pharma company will buy five brands from US-based Allergan for up to $650 million in cash. The ...

The table is limited by our hospital pharmacy's formulary; however, our purpose was to update the current literature. The table is intended for use as a guide when medications labeled for ...